Regression of human kidney cancer following allogeneic stem cell transplantation is associated with recognition of an HERV-E antigen by T cells.

Transplanted donor lymphocytes infused during hematopoietic stem cell transplantation (HSCT) have been shown to cure patients with hematological malignancies. However, less is known about the effects of HSCT on metastatic solid tumors. Thus, a better understanding of the immune cells and their target antigens that mediate tumor regression is urgently needed to develop more effective HSCT approaches for solid tumors. Here we report regression of metastatic renal cell carcinoma (RCC) in patients following nonmyeloablative HSCT consistent with a graft-versus-tumor effect. We detected RCC-reactive donor-derived CD8(+) T cells in the blood of patients following nonmyeloablative HSCT. Using cDNA expression cloning, we identified a 10-mer peptide (CT-RCC-1) as a target antigen of RCC-specific CD8(+) T cells. The genes encoding this antigen were found to be derived from human endogenous retrovirus (HERV) type E and were expressed in RCC cell lines and fresh RCC tissue but not in normal kidney or other tissues. We believe this to be the first solid tumor antigen identified using allogeneic T cells from a patient undergoing HSCT. These data suggest that HERV-E is activated in RCC and that it encodes an overexpressed immunogenic antigen, therefore providing a potential target for cellular immunity.

[1]  J. Yang,et al.  Identification of fibroblast growth factor-5 as an overexpressed antigen in multiple human adenocarcinomas. , 2001, Cancer research.

[2]  S. Depil,et al.  Expression of a human endogenous retrovirus, HERV-K, in the blood cells of leukemia patients , 2002, Leukemia.

[3]  R. Kurth,et al.  The viruses in all of us: characteristics and biological significance of human endogenous retrovirus sequences. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[4]  A. Greenwood,et al.  Comprehensive Analysis of Human Endogenous Retrovirus Transcriptional Activity in Human Tissues with a Retrovirus-Specific Microarray , 2005, Journal of Virology.

[5]  R. Kurth,et al.  Expression of human endogenous retrovirus K in melanomas and melanoma cell lines. , 2005, Cancer research.

[6]  R. Parker,et al.  Histologic Predictors of Renal Cell Carcinoma Response to Interleukin-2-Based Therapy , 2005, Journal of immunotherapy.

[7]  David J Griffiths,et al.  Endogenous retroviruses in the human genome sequence , 2001, Genome Biology.

[8]  W. Linehan,et al.  Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. , 2000, The New England journal of medicine.

[9]  A Sette,et al.  Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs. , 1996, Immunology today.

[10]  H. Pehamberger,et al.  An endogenous retrovirus derived from human melanoma cells. , 2003, Cancer research.

[11]  G. M. Ortiz,et al.  Detection of T lymphocytes specific for human endogenous retrovirus K (HERV-K) in patients with seminoma. , 2006, AIDS research and human retroviruses.

[12]  M. Leppert,et al.  Allogeneic Hematopoietic Cell Transplantation for Metastatic Renal Cell Carcinoma after Nonmyeloablative Conditioning , 2004, Clinical Cancer Research.

[13]  N. Ueno,et al.  The Second International Meeting on Allogeneic Transplantation in Solid Tumors , 2006, Bone Marrow Transplantation.

[14]  P. Coulie,et al.  A human endogenous retroviral sequence encoding an antigen recognized on melanoma by cytolytic T lymphocytes. , 2002, Cancer research.

[15]  J. P. McCoy,et al.  In vitro and in vivo evidence of PNH cell sensitivity to immune attack after nonmyeloablative allogeneic hematopoietic cell transplantation. , 2004, Blood.

[16]  Danielle W. Lu,et al.  Detecting the expression of human endogenous retrovirus E envelope transcripts in human prostate adenocarcinoma , 2003, Cancer.

[17]  A. Billiau,et al.  Experimental and clinical approaches for optimization of the graft-versus-leukemia effect , 2007, Nature Clinical Practice Oncology.

[18]  Brian Keith,et al.  Hypoxia-Inducible Factors, Stem Cells, and Cancer , 2007, Cell.

[19]  L. Hertle,et al.  Histologic subtype of metastatic renal cell carcinoma predicts response to combined immunochemotherapy with interleukin 2, interferon alpha and 5-fluorouracil. , 2007, European urology.